| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309535 | Clinica Chimica Acta | 2018 | 6 Pages |
Abstract
Serum HE4 was increased in kidney transplant recipients with decreased kidney function and renal fibrosis and was correlated with the severity of the disease, suggesting that HE4 has the potential to be used as a novel clinical biomarker for evaluating kidney function and predicting renal fibrosis in kidney transplant recipients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jinmei Luo, Fen Wang, Jianxin Wan, Zhuangjian Ye, Chumei Huang, Yuesu Cai, Min Liu, Ben-Quan Wu, Laisheng Li,